PGA Description
Microarray Expression Profiling of Rodent Models of Human Disease
The Institute for Genomic Research
The Jackson Laboratory
Medical College of Wisconsin
Boston University
Duke University
University of Pennsylvania
The Theme of our PGA: Examining Gene/Environment
Interactions in Rodent Models of Human Disease Using cDNA Microarrays to link
phenotype to genotype
Disease phenotypes
arise from complex interactions of organisms with their environments. While we
have a long history of associating genes and gene defects with a large array of
disease phenotypes, a growing body of data suggests that many disease
phenotypes arise from the interactions of genes with their environments,
including the genetic background in which the genes are expressed. Our goal is to
begin an exploration of these interactions using rodent models of human disease
and cDNA microarray assays to elucidate patterns of gene expression.
Overview of our PGA
As stated in RFA HL-99-024, The principal goal
of the NHLBI Programs for Genomic Applications (PGAs) will be to link genes to
function on a genomic scale in order to facilitate investigations in
physiological and pathophysiological mechanisms underlying heart, lung, blood,
and sleep function and disease. Together, researchers at The Institute for
Genomic Research (TIGR), The Jackson Laboratories (TJL), Boston University
(BU), Duke University (Duke), University of Pennsylvania (Penn) and Medical
College of Wisconsin (MCW), have developed a broad-based response to this
challenge in which we will develop a number of reagents, tools, and techniques
that will allow us to provide links between physiologically relevant animal
models of human disease and the genes that are differentially expressed in
those phenotypes. The starting point for our proposed studies is the
identification of rodent phenotypes that are of relevance to heart, lung, and
blood diseases as well as sleep disorders. Those animals will be identified and
characterized using heart, lung, kidney, vasculature, blood, and sleep responses
to environmental stressors, including diet, exercise, hypoxia and
pharmacological challenges. cDNA microarrays will then be used to assay
patterns of gene expression in these animals with wild-type animals and their
responses to identical stimuli as controls. We will present our data to the
research community, integrating it with available mapping, sequencing, and
physiological data.
Our PGA brings together biologists,
statisticians, computer scientists, engineers, and physicists who are will lend
their expertise to the achievement of our common goals. Our proposal builds on
existing expertise at TIGR in the analysis of gene expression using cDNA
microarrays, the mouse mutagenesis and phenotyping programs that have been
developed by The Jackson Laboratories and their collaborators at Penn, Duke,
and Boston Universities, and the efforts in rat genomics underway at the
Medical College of Wisconsin, including the generation of phenotypically
characterized consomic and congenic rat strains. Linking these programs are
coordinated efforts in informatics that will both facilitate data exchange
between consortium members and will make that data easily accessible to the
wider research community. Underlying this is a commitment to continuing to
develop and improve the reagents and assays a to provide a firm statistical
basis for any inferences that our assays provide. Finally, we maintain a
commitment to community service and will provide reagents, software, and data
generated as part of this PGA to the wider research community.
As we are generating expression profiles, we
will continue to develop and refine the laboratory resources necessary for
microarray analysis, including the creation of a well maintained, sequence
verified collection of reference cDNA clones, and the development of advanced
statistical techniques for microarray data analysis. We will develop web-based
presentations for our data and integrate it with the Gene Expression Database
(GXD; <http://www.informatics.jax.org/userdocs/aboutGXD.shtml>) at TJL,
the Rat Genome Database (RGD; <http://rgd.mcw.edu/>) at MCW, and the TIGR
Gene Index Databases (<http://www.tigr.org/tdb/tgi.html>). Finally, we
will provide educational and community outreach services to make both the
techniques and reagents developed as part of this project accessible to the
broader research community. This will include courses on microarray techniques
and analysis and a visitorÌs program that will allow researchers not directly
participating in this PGA to spend time at TIGR analyzing rodent models of HLBS
disorders.
The PGA will be divided into seven operational
components covering its various aspects:
|
Component
|
Principal Investigator
|
Institution
|
|
1
|
Administration and Coordination
|
John Quackenbush
|
TIGR
|
|
2
|
Mouse cDNA Microarray
Development and Analysis
|
John Quackenbush
|
TIGR
|
|
3
|
Rat Gene Expression Anatomy
Project
|
Norman Lee
|
TIGR
|
|
4
|
Applications to Mouse Models
|
Beverley Paigen
|
TJL
|
|
5
|
Advanced Analysis Techniques
|
Gary Churchill
|
TJL
|
|
6
|
Database Integration
|
Martin Ringwald
|
TJL
|
|
7
|
Education and Outreach
|
John Macauley
|
TJL
|
Overall Specific Aims of our PGA
The mission of our PGA will be to identify subsets
of genes that are particularly relevant to the biology, diagnosis, management,
treatment, and prevention of heart, lung, blood, and sleep related disorders
and to prioritize the information for further focused study. We will achieve
this through microarray analysis of patterns of gene expression in mouse and
rat models of these disorders, with a focus on developing an understanding of
how environmental and genetic factors combine to produce the disease phenotype.
To meet this ambitious goal, we have assembled a diverse group of highly
skilled research scientists with diverse but complementary talents. The
research plan we will outline represents the efforts of those individuals to
contribute their expertise to meeting what we believe will be a most rewarding
challenge. The division of this proposal into Components has allowed the
participating investigators to highlight their primary research interests and
expertise. However, the division is, in many ways an artificial one. All of the
participating investigators are committed to a collaborative effort to meet our
overall objective and that the ultimate success of the PGA will rely on an
integrated approach to large-scale, discovery-driven research. Our underlying
hypothesis in this proposal is that through the careful design of our
experiments, the thoughtful selection of rodent phenotypes, the integration of
diverse data, and the learned analysis of experts in these disorders, we will
not only recapitulate what is known about these diseases, but that we also
discover new leads that will allow us to expand our understanding. With those
cautions and caveats, we present the following outline for our PGA:
Specific Aim 1: To establish an Administration and Coordination Component.
The goals of this Component will be to create an
environment in which the diverse collection of research scientists
participating in this PGA will be able to most efficiently work together and in
which the PGA as a whole can adapt to experimental difficulties and advances,
including those made by researchers outside of this specific PGA. Our plan to
achieve these goals are outlined in the Specific Aims for this Component:
Specific Aim 2:
To establish a Mouse cDNA Microarray Development and Analysis Component.
- Specific Aim 2.1:We will develop mouse cDNA
microarrays containing approximately 30,000 sequence-verified cDNA clones
representing known genes and genes of uncharacterized functions, focusing on
unknowns that have orthologues in humans and rats and those with mapping
information.
- Specific Aim 2.2:We will use the cDNA
microarrays developed in Specific Aim 2.1 to analyze patterns of Gene
Expression in Normal Tissue and in mouse models of disease. The specific
applications will be detailed in the description of Component 4: Applications
of Microarray Analysis to the Mouse.
- Specific Aim 2.3:We will work with the
informatics group at The Jackson Laboratories to develop an integrated
presentation of microarray expression data. In particular, we will integrate
existing microarray analysis databases at TIGR with the Gene Expression
Database at TJL in order to capture and represent the appropriate phenotypic
and microarray expression data to allow researchers to prioritize information for further focused
study.
- Specific Aim 2.4: We will work with the
Advanced Analysis Techniques Group (Component 5) at The Jackson
Laboratories at Jackson Laboratories to refine our experimental design and our
analysis techniques. While we will use standard analysis techniques including
hierarchical clustering techniques and self-organizing maps to the identification
of genes that contribute to specific disease states, we will also investigate
novel approaches to the identification of patterns of gene expression.
Specific Aim 3: To establish a Rat Gene Expression Anatomy Component.
Microarray analysis of consomic rats offer an unprecedented means to link complex gene expression profiles to pathophysiological pathways. A consomic rat has a
full-length chromosome from one inbred strain introgressed onto the background
of another inbred strain. Hence, the contribution of genes on each chromosome
can be assessed by phenotyping and expression profiling. Comparisons between
the congenic strains will provide valuable insights into the genomic pathways
(ÏclusteredÓ gene expression patterns) that differ between strains and how
these differences might be connected to a particular pathogenic phenotype of
the animal.
- Specific Aim 3.1
Generate baseline expression
profiles for consomic strains.
- Specific Aim 3.2 Determine the
effects of chronic stressors on the expression profile of selected consomics
with interesting phenotypes.
- Specific Aim 3.3 Generate
an accessible expression profile database for the research community.
Specific Aim 4: To establish an Applications to Mouse Models Component.
The theme of this application is a study of the
interactions of genes with their environment to understand the generation of a
disease phenotype. The mouse microarrays and the protocols and analysis tools
that will be developed in the Component 3 represent an unprecedented reagent
for the genome scale analysis of gene expression. However, to achieve the goal
outlined in our theme, we will require mouse models that are well characterized
by careful phenotypic analysis of their responses to various stresses. This
component will screen mouse models of human heart, lung, blood, and sleep
disorders and assist in developing experiments that will allow us to:
- Specific Aim 4.1: Determine
which genes are expressed in tissues of relevance to heart, lung, blood, and
sleep phenotypes.
- Specific Aim 4.2: Determine
the genetic control of mRNA levels in genetically segregating animals by
examining their gene expression patterns.
- Specific Aim 4.3: Compare
gene expression in strains that have low phenotype values with strains that
have high phenotype values.
- Specific Aim 4.4: Use
microarrays to characterize new mutants that have phenotypes relevant to heart,
lung, blood, and sleep disorders.
- Specific Aim 4.5: Measure the changes in gene
expression patterns of relevant phenotypes when the environment changes.
Specific Aim 5: To establish an Advanced Analysis Techniques Component.
The members of this Component, who are trained biostatisticians and
software developers, will work closely with the members of the other Components
to refine experimental design and to develop novel approaches to data analysis.
It is our hope that this will allow us to generate the most comprehensive and
cost-effective data in the most efficient manner possible. To meet these
objectives, this Component will undertake the following research plan:
- Specific Aim 5.1: We will develop
statistical models for gene expression microarray data. A simulation tool will
be developed in Matlab for validation studies of methods proposed in Specific
Aim 5.3.
- Specific Aim 5.2: We will develop
efficient and robust designs for microarray experiments. General principles of
design for microarrays will be derived. Specific applications will be developed
and implemented in collaboration with other investigators participating in this
PGA.
- Specific Aim 5.3: We will develop
and validate analysis methods for microarray experiments based on a general
ANOVA framework. Tools for data analysis will be implemented in Matlab
software. Methods will be applied to experiments carried out as part of the
overall project.
Specific Aim 6: To establish a Database Integration Component.
The
unprecedented quantity of gene expression data that this PGA will generate for
rodent models of HLBS disorders presents a number of challenges to effective
analysis and interpretation. In order to fully understand the changes in
expression that will be observed, we must integrate this data with phenotype,
genotype, and information, including tissue distribution and time course
expression data gleaned from previous studies. The Jackson Laboratories
maintain two important resources, the Mouse Genome Database (MGD) and the Mouse
Gene Expression Database (GXD). The objectives of this Component will be to
integrate these with the Gene Expression Laboratory databases that have been
developed for microarray analysis at TIGR in order to provide an integrated
view of the data to participants in this PGA and to the community as a whole.
This will be achieved through meeting the following goals:
- Specific Aim 6.1: Establish a laboratory
database for microarray expression data at The Jackson Laboratory to support
the experimental work and the analysis of the data generated by the proposed
project.
- Specific Aim 6.2:Incorporate the gene
expression data into the Gene Expression Database (GXD) where they will be
available to the community, integrated with other expression data and with
genetic, genomic, and phenotype data for the laboratory mouse.
Specific Aim 7: To establish an Education and Outreach Component.
The advances developed as part of this PGA will
provide researchers with the means to explore complex relationships between
genes and the environment in HLBS disorders. We anticipate that there will be
broad interest in learning the techniques and in gaining access to those
resources. Consequently, the participants in this PGA are committed to a
proactive community outreach program that goes beyond posting data on a
website. We propose to both offer courses, training researchers in the
applications of cDNA microarray technology and to create an environment where
researchers with relevant biological models can visit TIGR to perform
microarray assays and analyze data. Specifically:
- Specific Aim 7.1: We will develop and offer a
laboratory-based cDNA microarray data generation and analysis course to be offered
at The Jackson Laboratories.
- Specific Aim 7.2: We will
institute a visitorÌs program, allowing researchers not participating in this
research program, to spend a week at TIGR conducting microarray assays and
analyzing data in collaboration with the TIGR research scientists. Participants
will be selected based on applications to be reviewed
|